R-3750

· Rise Therapeutics LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for R-3750, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: R-3750 in Patients With Mild to Moderate Ulcerative Colitis [Phase 1]